Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $47.5000 (5.56%) ($45.5000 - $48.5000) on Sun. May. 12, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.04% (three month average) | RSI | 51 | Latest Price | $47.5000(5.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -4.02% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.02% (StdDev 8.04%) | Hourly BBV | 0 () | Intraday Trend | -2.1% | | | |
|
1 - 5 Day Possible Target | $40.05(-15.68%) | 5 Day Moving Average | $45.9(3.49%) | 10 Day Moving Average | $46.89(1.3%) | 20 Day Moving Average | $47.44(0.13%) | To recent high | -35.6% | To recent low | 23.4% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |